Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.89
-0.90 (-0.44%)
AAPL  262.08
-2.27 (-0.86%)
AMD  200.06
-0.06 (-0.03%)
BAC  52.43
-0.93 (-1.74%)
GOOG  304.19
+0.25 (0.08%)
META  643.59
+0.37 (0.06%)
MSFT  397.85
-1.75 (-0.44%)
NVDA  185.94
-2.04 (-1.09%)
ORCL  157.12
+0.95 (0.61%)
TSLA  409.58
-1.74 (-0.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.